NCT03808493View on ClinicalTrials.gov

A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

March 12, 2019

Study Completion Date

March 12, 2019

Conditions

Japanese Healthy Adult Male

Interventions

DRUG

TAK-438 OD

TAK-438 OD tablet

DRUG

TAK-438

TAK-438 tablet

Trial Locations (1)

Unknown

Sekino Clinical Pharmacology Clininc, Toshima-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY